Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 967-80-6
2. Sulfaquinoxaline Sodium Salt
3. Sulfaquinoxaline (sodium Salt)
4. Sq-na
5. Sodium;(4-aminophenyl)sulfonyl-quinoxalin-2-ylazanide
6. Sodium (4-aminophenyl)sulfonyl-quinoxalin-2-yl-azanide
7. N'1-quinoxalin-2-ylsulphanilamide Sodium Salt
8. 21223epj40
9. Benzenesulfonamide, 4-amino-n-2-quinoxalinyl-, Monosodium Salt
10. Sulfquinoxaline Sodium
11. Sodium Sulfaquinoxaline
12. Sr-05000001773
13. Unii-21223epj40
14. N'1-quinoxalin-2-ylsulphanilamide, Sodium Salt
15. Einecs 213-526-2
16. Sulfaquinoxalinesodium
17. Sulphaquinoxaline Sodium
18. Mls002153979
19. Spectrum1501145
20. Chembl1527324
21. Hms500b17
22. Hy-b1282a
23. Dtxsid30914383
24. Hms1570c04
25. Hms2092h03
26. Hms2097c04
27. Hms2230e09
28. Hms3369g20
29. Hms3714c04
30. Ccg-40204
31. Mfcd00799608
32. S5031
33. Akos024255725
34. Akos024374990
35. Ccg-267727
36. Cs-8211
37. Ks-5332
38. Ncgc00017031-01
39. Ncgc00017031-02
40. Ncgc00017031-03
41. Ncgc00094910-01
42. Ncgc00094910-02
43. Sulfaquinoxaline Sodium Salt, >=92.5%
44. Cas-967-80-6
45. Smr001233316
46. Db-057646
47. Sulfaquinoxaline Sodium [green Book]
48. Ft-0633200
49. D70851
50. 967s806
51. A832301
52. Q-201764
53. Sr-05000001773-1
54. Sr-05000001773-3
55. N1-(quinoxalin-2-yl)sulphanilamide Sodium Salt
56. Q27253507
57. Sodium (4-aminophenyl)sulfonyl-(2-quinoxalinyl)azanide
58. Sodium (4-aminophenylsulfonyl)(quinoxalin-2-yl)amide
59. Sulfaquinoxaline Sodium 100 Microg/ml In Acetonitrile
60. Sodium ((4-aminophenyl)sulfonyl)(quinoxalin-2-yl)amide
61. Sodium (4-aminobenzene-1-sulfonyl)(quinoxalin-2-yl)azanide
62. Sulfaquinoxaline Sodium, Antibiotic For Culture Media Use Only
| Molecular Weight | 322.32 g/mol |
|---|---|
| Molecular Formula | C14H11N4NaO2S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 322.05004106 g/mol |
| Monoisotopic Mass | 322.05004106 g/mol |
| Topological Polar Surface Area | 95.3 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 448 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Sulfaquinoxaline Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulfaquinoxaline Sodium, including repackagers and relabelers. The FDA regulates Sulfaquinoxaline Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulfaquinoxaline Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulfaquinoxaline Sodium supplier is an individual or a company that provides Sulfaquinoxaline Sodium active pharmaceutical ingredient (API) or Sulfaquinoxaline Sodium finished formulations upon request. The Sulfaquinoxaline Sodium suppliers may include Sulfaquinoxaline Sodium API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sulfaquinoxaline Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sulfaquinoxaline Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sulfaquinoxaline Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sulfaquinoxaline Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sulfaquinoxaline Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sulfaquinoxaline Sodium suppliers with NDC on PharmaCompass.
Sulfaquinoxaline Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulfaquinoxaline Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulfaquinoxaline Sodium GMP manufacturer or Sulfaquinoxaline Sodium GMP API supplier for your needs.
A Sulfaquinoxaline Sodium CoA (Certificate of Analysis) is a formal document that attests to Sulfaquinoxaline Sodium's compliance with Sulfaquinoxaline Sodium specifications and serves as a tool for batch-level quality control.
Sulfaquinoxaline Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Sulfaquinoxaline Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulfaquinoxaline Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulfaquinoxaline Sodium EP), Sulfaquinoxaline Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulfaquinoxaline Sodium USP).
LOOKING FOR A SUPPLIER?
